Differential expression of metallothioneins in human prion diseases

Dementia and Geriatric Cognitive Disorders

Volumn 11, Issue 5, 2000, Pages 251-262

  Kawashima, Toshiro ^a,b   Doh Ura, Katsumi ^a   Torisu, Miho ^a,b   Uchida, Yoko ^c   Furuta, Akiko ^a   Iwaki, Toru ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Astrocyte; Copper; Immunoblotting; Immunohistochemistry; Metallothionein; Prion disease; Prion protein

Indexed keywords

PRION PROTEIN;

ARTICLE; ASTROCYTE; CREUTZFELDT JAKOB DISEASE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033844035     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017247     Document Type: Article

References (34)

1. Aschner M, Cherian MG, Klaassen CD, Palmiter RD, Erickson JC, Bush AI: Metallothioneins in brain - the role in physiology and pathology. Toxicol Appl Pharmacol 1997;142: 229-242.
2. Kägi JHR, Schäffer A: Biochemistry of metallothionein. Biochemistry 1988;27:8509-8515.
3. Aschner M: The functional significance of brain metallothioneins. FASEB J 1996;10: 1129-1136.
4. Bremner I: Interactions between metallothionein and trace elements. Prog Food Nutr Sci 1987;11:1-37.
5. Dunn MA, Blalock TL, Cousins RJ: Metallothioncin. Proc Soc Exp Biol Med 1987;185: 107-119.
6. Quaife CJ, Findley SD, Erickson JC, Froelick GJ, Kelly EJ, Zambrowicz BP, Palmiter RD: Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 1994; 33:7250-7259.
7. Uchida Y, Takio K, Titani K, Ihara Y, Tomonaga M: The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 1991;7:337-347.
8. Palmiter RD, Findley SD, Whitmore TE, Durnam CM: MT-III, a brain-specific member of the metallothionein gene family. Proc Natl Acad Sci USA 1992;89:6333-6337.
9. Prusiner SB: Novel proteinaccous infectious particles cause scrapie. Science 1982;216:136-144.
10. Lampert PW, Gajdusek DC, Gibbs CJ Jr: Subacute spongiform virus encephalopathics. Scrapie, kuru and Creutzfeldt-Jakob disease: A review. Am J Pathol 1972;68:626-652.
11. Masters CL, Richardson EP Jr: Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease): The nature and progression of spongiform change. Brain 1978;101:333-344.
12. Duguid JR, Rohwer RG, Seed B: Isolation of cDNAs of scrapie-modulated RNAs by subtractive hybridization of a cDNA library. Proc Natl Acad Sci USA 1988;85:5738-5742.
13. Duguid JR, Bohmont CW, Liu N, Tourtellotte WW: Changes in brain gene expression shared by scrapie and Alzheimer disease. Proc Natl Acad Sci USA 1989;86:7260-7264.
14. Dandoy-Dron F, Guillo F, Benboudjema L, Deslys J-P, Lasmezas C, Dormont D, Tovey MG, Dron M: Gene expression in scrapie. J BiolChem 1998;273:7691-7697.
15. Furukawa H, Kitamoto T, Hashiguchi H, Tateishi J: A Japanese case of Creutzfeldt-Jakob disease with a point mutation in the prion protein gene at codon 210. J Neurol Sci 1996;141: 120-122.
16. Hoque MZ, Kilamoto T, Furukawa H, Muramoto T, Tateishi J: Mutation in the prion prolein gene at codon 232 in Japanese patients with Creutzfeldt-Jakob disease: A clinico-pathological, immunohistochemical and transmission study. Acta Neuropathol (Berl) 1996; 92:441-446.
17. Furukawa H, Kitamoto T, Tanaka Y, Tateishi J: New variant prion protein in a Japanese family with Gerstmann-Sträussler syndrome. Brain Res Mol Brain Res 1995;30:385-388.
18. Tanaka Y, Mineniatsu K, Moriyasu H, Yamaguchi T, Yutani C, Kitamoto T, Furukawa H: A Japanese family with a variant of Gerstmann-Sträussler-Scheinker disease. J Neurol Neurosurg Psychiatry 1997;62:454-457.
19. Kaneko Y, Kitamoto T, Tateishi J, Yamaguchi K: Ferritin immunohistochemistry as a marker for microglia. Acta Neuropathol 1989;79:129-136.
20. Mizzen CA, Cartel NJ, Yu WH, Fraser PE, McLachlan DR: Sensitive detection of metallothioneins-1,-2 and -3 in tissue homogenates by immunoblotting: A method for enhanced membrane transfer and retention. J Biochem Biophys Methods 1996;32:77-83.
21. Kitamoto T, Shin R-W, Doh-ura K, Tomokane N, Miyazono M, Muramoto T, Tateishi J: Ab7 normal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol 1992;140:1285-1294.
22. Nakajima K, Suzuki K, Otaki N, Kimura M: Detection of metallothionein in brain. Methods Enzymol 1991;205:387-395.
23. Blaauwgeers HGT, Sillevis Smitt PAE, de Jong JMBV, Troost D: Distribution of metallothionein in the human central nervous system. Glia 1993;8:62-70.
24. Miyazono M, Iwaki T, Kitamoto T, Kaneko Y, Doh-ura K, Tateishi J: A comparative immunohistochcmical study of kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque formation. Am J Pathol 1991;139:589-598.
25. Luza SC, Speisky HC: Liver copper storage and transport during development: Implications for cylotoxicity. Am J Clin Nutr 1996;63: 812S-820S.
26. Hornshaw MP, McDermott JR, Candy JM: Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem Biophys Res Commun 1995; 207:621-629.
27. Hornshaw MP, McDermott JR, Candy JM, Lakey JH: Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: Structural studies using synthetic peptides. Biochem Biophys Res Commun 1995;214:993-999.
28. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck T, von Bohlen A, Schulz-Schaeffer W, Giese A, Westaway D. Kretzschmar H: The cellular prion protein binds copper in vivo. Nature 1997;390: 684-687.
29. Miura T, Hori-i A, Takeuchi H: Metal-dependent α-helix formation promoted by the glycine-rich octapeptide region of prion protein. FEBS Lett 1996;396:248-252.
30. Pan K-M, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, Prusiner SB: Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 1993;90:10962-10966.
31. Kondo Y, Rusnak JM, Hoyt DG, Settineri CE, Pitt BR, Lazo JS: Enhanced apoptosis in metallothionein null cells. Mol Pharmacol 1997;52: 195-201.
32. Giese A, Groschup MH, Hess B, Kretzschmar HA: Neuronal cell death in scrapie-infected mice is due to apoptosis. Brain Pathol 1995;5: 213-221.
33. Lucassen PJ, Williams A, Chung WCJ, Fraser H: Detection of apoptosis in murine scrapie. Neurosci Lett 1995;198:185-188.
34. Lucas M, Izquierdo G, Munoz C, Solano F: Internucleosomal breakdown of the DNA of brain cortex in human spongiform encephalopathy. Neurochem Int 1997;31:241-244.